These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20861719)

  • 1. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review.
    Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ
    Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation-the final frontier.
    Govindan M; Savelieva I; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):36S-50S. PubMed ID: 20940451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
    Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
    Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation: mechanistic insights and treatment options.
    Mathew ST; Patel J; Joseph S
    Eur J Intern Med; 2009 Nov; 20(7):672-81. PubMed ID: 19818285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in congestive heart failure.
    Seiler J; Stevenson WG
    Cardiol Rev; 2010; 18(1):38-50. PubMed ID: 20010337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac rate normalization in chronic atrial fibrillation: comparison of long-term efficacy of treatment with amiodarone versus AV node ablation and permanent His-bundle pacing.
    Kirkutis A; Poviliŭnas A; Griciene P; Polena S; Yang S; Yalamanchi G; Gintautas J
    Proc West Pharmacol Soc; 2004; 47():69-70. PubMed ID: 15633616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.